Back to Search
Start Over
T-cell Malignancies Market Dynamics: Key Insights on Acute Lymphocytic Leukemia, Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Anaplastic Large Cell Lymphoma, and Adult T-cell Leukemia/Lymphoma | DelveInsight
- Source :
- PR Newswire. December 11, 2024
- Publication Year :
- 2024
-
Abstract
- T-cell malignancies account for about 10-15% of all lymphoid malignancies, and their treatment often involves chemotherapy, immunotherapy, or stem cell transplantation. These cancers can be particularly challenging due to their [...]
- Subjects :
- United States. Food and Drug Administration
Pfizer Inc. -- Forecasts and trends
Novartis AG -- Forecasts and trends
Beam Therapeutics Inc. -- Forecasts and trends
Business -- Research
T cells -- Forecasts and trends
Antineoplastic agents -- Forecasts and trends
Stem cells -- Forecasts and trends -- Transplantation
Non-Hodgkin's lymphomas -- Forecasts and trends
Immunotherapy -- Forecasts and trends
Chemotherapy -- Forecasts and trends
Adults -- Forecasts and trends
Cancer -- Chemotherapy
Antimitotic agents -- Forecasts and trends
Market trend/market analysis
Business
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.819583443